Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1983-03-22
1985-04-23
Schwartz, Richard A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548333, 514826, A61K 31415, C07D23506
Patent
active
045130019
ABSTRACT:
Novel compounds with .beta.-adrenergic properties comprising 1-[1-benzimidazolyl] N-[2-(4-hydroxy 3-methoxy phenyl) 2-hydroxy ethyl]3-amino butane, corresponding to the following formula ##STR1## as well as its addition salts with pharmaceutically acceptable non-toxic inorganic or organic acids, and the hydrates of said salts. These compounds are particularly useful for the treatment of asthma and in the case of premature labor.
REFERENCES:
patent: 3905990 (1975-09-01), Ehrmann et al.
Joannic Michel
Pesson Marcel
Roquet Francoise
Laboratoire Roger Bellon
Schwartz Richard A.
LandOfFree
.beta.-Adrenergic 1-[1-benzimidazolyl]-N-[2-(4-hydroxy-3-methoxy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with .beta.-Adrenergic 1-[1-benzimidazolyl]-N-[2-(4-hydroxy-3-methoxy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and .beta.-Adrenergic 1-[1-benzimidazolyl]-N-[2-(4-hydroxy-3-methoxy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-36783